Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, By Product Type (Sphincterotomes, Lithotripter, Endoscopes, Accessories, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others), Application (Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Pancreatitis, Others), End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Others) - Industry Trends and Forecast to 2030.
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Analysis and Size
The rapid rise in rise in awareness regarding endoscopic retrograde cholangiopancreatography devices is amongst the important factor expected to intensify the growth and demand for endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market. In addition, the increase in the increase in the cases of benign tumors of the pancreas and liver across the globe and vaginal cancer, along with the rise in awareness programs, are also expected to contribute to the growth in the global market over the forecast period of 2023 to 2030.
Data Bridge Market Research analyses that the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market which was USD 524.65 million in 2022, is expected to reach USD 867.96 million by 2030, and is likely to undergo a CAGR of 3.22% during the forecast period. “Cannulas” dominates the product type segment of the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market owing to the growing prevalence of biliary disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product Type (Sphincterotomes, Lithotripter, Endoscopes, Accessories, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others), Application (Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Pancreatitis, Others), End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
OLYMPUS CORPORATION (Japan), CONMED Corporation (U.S.), TeleMed Systems, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cook (U.S.), Merit Medical Systems (U.S.), KARL STORZ SE & Co. KG (Germany), Braun Melsungen AG (Germany), BD (Becton, Dickinson and Company) (U.S.), FUJIFILM Corporation (Japan), Medtronic (Ireland), HOBBS MEDICAL, INC. (U.S.), SureCare (U.S.), Richard Wolf GmbH (Germany), PENTAX Medical (HOYA Corporation) (Japan), Johnson & Johnson (U.S.), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Karl Storz Endoscopy-America, Inc. (U.S.), Olympus Medical Systems (Japan) |
|
Market Opportunities |
|
Market Definition
An endoscopic retrograde cholangiopancreatography (ERCP) device usually utilizes a combination of fluoroscopic imaging and luminal endoscopy for the diagnosis and treatment of pancreaticobiliary system associated disorders. Percutaneous transhepatic cholangiography (PTC) is a type of therapeutic technique used to observe the anatomy of the biliary duct.
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Dynamics
Drivers
- Growing Prevalence of Biliary Disorders
The increasing incidence of biliary disorders such as gallstones, bile duct obstructions, and pancreatitis is driving the demand for ERCP and PTC devices for diagnosis and treatment.
- Advancements in Technology
Technological advancements in endoscopy and imaging techniques have improved the effectiveness and safety of ERCP and PTC procedures, leading to increased adoption.
Opportunities
- Emerging Markets
There is significant growth potential in emerging markets where there is an increasing focus on improving healthcare infrastructure and access to advanced medical technologies.
Restraints/Challenges
- High Cost of Devices
The cost of ERCP and PTC devices can be relatively high, which can limit their adoption in certain healthcare settings with budget constraints.
- Complications and Risks
ERCP and PTC procedures carry certain risks and complications, including bleeding, infection, and pancreatitis, which may deter some patients and physicians from opting for these procedures.
- Regulatory Challenges
Compliance with regulatory requirements and obtaining approvals for new devices can pose challenges for manufacturers in the ERCP and PTC device market.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Scope
The global endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Product Type
- Sphincterotomes
- Lithotripter
- Endoscopes
- Accessories
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Baskets
- Others
Application
- Jaundice
- Stone Removal
- Postoperative or Posttraumatic Bile Leakage
- Pancreatitis
- Others
End-User
- Jaundice
- Stone Removal
- Postoperative or Posttraumatic Bile Leakage
- Pancreatitis
- Others
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Regional Analysis/Insights
The endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market is analysed and market size insights and trends are provided by product type, application and end-user as referenced above.
The countries covered in the global endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
North America dominates the endoscopic retrograde cholangiopancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC) devices market due to rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.
Asia-Pacific is the expected region in terms of growth in endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market due to rise in the prevalence of pediatric genetic diseases in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Share Analysis
The endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market.
Some of the major players operating in the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market are:
- OLYMPUS CORPORATION (Japan)
- CONMED Corporation (U.S.)
- TeleMed Systems, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Cook (U.S.)
- Merit Medical Systems (U.S.)
- KARL STORZ SE & Co. KG (Germany)
- Braun Melsungen AG (Germany)
- BD (Becton, Dickinson and Company) (U.S.)
- FUJIFILM Corporation (Japan)
- Medtronic (Ireland)
- HOBBS MEDICAL, INC. (U.S.)
- SureCare (U.S.)
- Richard Wolf GmbH (Germany)
- PENTAX Medical (HOYA Corporation) (Japan)
- Johnson & Johnson (U.S.)
- Stryker Corporation (U.S.)
- Smith & Nephew plc (U.K.)
- Karl Storz Endoscopy-America, Inc. (U.S.)
- Olympus Medical Systems (Japan)
SKU-
